APA (7th ed.) Citation

Barrios, C. H., Hernandez-Barajas, D., Brown, M. P., Lee, S., Fein, L., Liu, J., . . . Rha, S. (2012). Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma. Cancer (0008543X), 118(5), 1252. https://doi.org/10.1002/cncr.26440

Chicago Style (17th ed.) Citation

Barrios, Carlos H., et al. "Phase II Trial of Continuous Once-daily Dosing of Sunitinib as First-line Treatment in Patients with Metastatic Renal Cell Carcinoma." Cancer (0008543X) 118, no. 5 (2012): 1252. https://doi.org/10.1002/cncr.26440.

MLA (9th ed.) Citation

Barrios, Carlos H., et al. "Phase II Trial of Continuous Once-daily Dosing of Sunitinib as First-line Treatment in Patients with Metastatic Renal Cell Carcinoma." Cancer (0008543X), vol. 118, no. 5, 2012, p. 1252, https://doi.org/10.1002/cncr.26440.